NPM1 and acute myeloid leukemia: We found that Wnt signaling is also active in blasts derived from patients bearing NPM1 mutations as indicated by the nuclear accumulation of active β-catenin and overexpression of one of its target genes, AXIN2. This finding suggests that NPMc+ may be responsible for Wnt signaling activation in an AML subtype without known translocation products.